Tresiba (Insulin Degludec): Flexibility in day-to-day dosing time when needed

Poor glucose control in patients with diabetes can ultimately result in diabetic complications that can be
devastating for the patient’s quality of life, life-shortening, and expensive to treat for national healthcare systems.
Current expert guidelines on the treatment of type 2 diabetes therefore advocate the addition of insulin to agents
such as metformin as early as necessary in the pursuit of recommended HbA1c targets.¹